Searched for
WOCKHARDT NEWS
Wockhardt shares pause massive 36% rally in 5 sessions; slip 7%. What’s behind the selloff?Wockhardt shares dropped after a recent surge, as investors took profits. This followed the US FDA approval of ZAYNICH, an antibiotic for u...- Gainers & Losers: Paytm, Godrej Industries among 8 big stock movers on ThursdayIndian benchmark indices ended marginally lower amid weakness in FMCG, IT and PSU banking stocks. Paytm surged after reporting quarterly pr...
- Gainers & Losers: Vodafone Idea, ONGC among 7 big stock movers on WednesdayDomestic markets surged Wednesday as oil fell below $100. Nifty and Sensex rose over 1%, with notable stock-specific movements across secto...
- Smallcap winners! Wockhardt, Tata Tech, CAMS, other stocks rally up to 11% despite overall market weaknessSmallcap stocks outperformed on Tuesday despite weak broader markets, with Wockhardt, Tata Tech and CAMS gaining up to 11% on strong Q4 ear...
- Wockhardt Ltd dumps US generic pharma segment after losses, bets on antibiotics and insulinWockhardt Ltd has decided to shut down its loss-making US generics business to channel its energy and funds into developing new antibiotics...
- Wockhardt shares skyrocket 18% to fresh 52-week high. Here’s why?Shares of Wockhardt surged 18% in early trading to reach a new 52-week high of Rs 811.50 on NSE. The sharp increase followed the company's ...
- Wockhardt board approves plan to raise Rs 1,000 cr via rights issuehe board of directors in its meeting held on Thursday considered and approved the issue of equity shares by way of a rights issue to the ex...
- Pharma sector offers many good bets: Kunj BansalMedium- and long-term investors should not be too adventurous with the Wockhardt stock, because the risks seem to be higher.
- Difficult for Wockhardt to find sustainable investor interest: Sonam Udasi, IDBI CapitalThe spate of negative news on Wockhardt has been quite surprising. It will be extremely difficult for it to find any sustainable investor i...
- Avoid buying Wockhardt for now: Mehraboon IraniWhen you start having regulatory problems the best thing to do as a sane investor is to stay away.
- Another Wockhardt plant under MHRA scannerThis is the drug maker's second plant whose GMP certificate has been taken away by MHRA and the third to face regulatory heat this year.
- Wockhardt is stock: Ashwani Gujral"Wockhardt is a difficult stock to trade. It used to be in this range of about 310. On the upside maybe say 460. It was down from that rang...
- Avoid Fresenius Kabi: Ashwani GujralFresenius Kabi is probably a low volume stock that you should avoid but clearly action is likely to shift in the smaller stocks in terms of...
- Buy Wockhardt for a stop of 325: Ashwani GujralWockhardt has lots of news attached to it. So it is not a very comfortable stock in terms of trading.
- High Court stays winding up order against Wockhardt; stock downWockhardt won temporary reprieve in the Bombay High Court as a division bench conditionally stayed its winding-up until May 3.
- High Court stays winding up order against WockhardtWockhardt won temporary reprieve in the Bombay High Court as a division bench conditionally stayed its winding-up until May 3.
- Wockhardt tumbles nearly 5% on BSEWockhardt on Thursday plunged nearly 5% on BSE amid media reports that rival Sun Pharma has opposed the settlement between Wockhardt and so...
- Wockhardt looks strong, but not for long term: Deepak MohoniWockhardt is very strong right now. It is not so great for the long term.
- Fortis Healthcare gains 4 pc; Wockhardt up 2.32% on BSEShares of Fortis Healthcare gained nearly four per cent in the morning trade on Bombay Stock Exchange a day after the company said it will ...
- Vetoquinol acquires Wockhardt's veterinary businessFrench veterinary company Vetoquinol has acquired the veterinary business of pharma company Wockhardt, pipping bigger rivals such as Pfizer...
Load More
